In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of MAIA Biotechnology Inc (AMEX: MAIA) was $1.71 for the day, down -4.47% from the previous closing price of $1.79. In other words, the price has decreased by -$4.47 from its previous closing price. On the day, 91762.0 shares were traded. MAIA stock price reached its highest trading level at $1.8164 during the session, while it also had its lowest trading level at $1.71.
Ratios:
Our analysis of MAIA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 08 ’25 when Guerrero Ramiro bought 20,000 shares for $1.50 per share. The transaction valued at 30,000 led to the insider holds 588,218 shares of the business.
Smith Stan bought 66,666 shares of MAIA for $99,999 on May 08 ’25. The Director now owns 1,271,726 shares after completing the transaction at $1.50 per share. On Mar 03 ’25, another insider, Guerrero Ramiro, who serves as the Director of the company, bought 33,333 shares for $1.50 each. As a result, the insider paid 50,000 and bolstered with 568,218 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MAIA now has a Market Capitalization of 51825484 and an Enterprise Value of 50756824.
Stock Price History:
The Beta on a monthly basis for MAIA is 0.09, which has changed by -0.5839416 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, MAIA has reached a high of $5.99, while it has fallen to a 52-week low of $1.40. The 50-Day Moving Average of the stock is -3.20%, while the 200-Day Moving Average is calculated to be -22.86%.
Shares Statistics:
MAIA traded an average of 214.14K shares per day over the past three months and 248510 shares per day over the past ten days. A total of 29.59M shares are outstanding, with a floating share count of 21.97M. Insiders hold about 27.51% of the company’s shares, while institutions hold 4.87% stake in the company. Shares short for MAIA as of 1745971200 were 576572 with a Short Ratio of 2.69, compared to 1743379200 on 737417. Therefore, it implies a Short% of Shares Outstanding of 576572 and a Short% of Float of 2.3.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of MAIA Biotechnology Inc (MAIA) is the result of assessments by 1.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.19 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.75 and -$0.75 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.69, with 1.0 analysts recommending between -$0.69 and -$0.69.
